Text and Data Mining valid from 2018-11-01
First Online: 9 November 2018
Compliance with Ethical Standards
: Jillian L. Simard has two patents issued - #8940724, Quinoline derivatives and their uses, and #8765940, Heterocyclic compounds and their uses. Both are licensed to Amgen, but Dr. Simard has no current financial interest in Amgen.Melanie Smith declares that she has no conflict of interest.Sunandana Chandra has received consulting fees from Bristol-Myers Squibb, EMD Serono, Biodesix, Sanofi Genzyme, and Regeneron.
: This article does not contain any studies with human or animal subjects performed by any of the authors.